Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cadisegliatin (TTP-399) is a potential activator of liver-selective glucose kinase (GK) with hypoglycaemic effects and can be used in the study of type 2 diabetes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 916.00 | |
50 mg | 6-8 weeks | $ 1,190.00 | |
100 mg | 6-8 weeks | $ 1,860.00 |
Description | Cadisegliatin (TTP-399) is a potential activator of liver-selective glucose kinase (GK) with hypoglycaemic effects and can be used in the study of type 2 diabetes. |
Molecular Weight | 455.63 |
Formula | C21H33N3O4S2 |
CAS No. | 859525-02-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cadisegliatin 859525-02-3 inhibitor inhibit